John Mark O'Mahony - 29 Jan 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Chief Manufacturing Officer
Signature: /s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
Issuer symbol: LPTX
Transactions as of: 29 Jan 2024
Transactions value $: $0
Form type: 4
Date filed: 31 Jan 2024, 21:34
Previous filing: 30 Jan 2024
Next filing: 04 Oct 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Employee Stock Option (Right to Buy)	Award	$0	+85K		$0.00	85K	29 Jan 2024	Common Stock	85K	$2.68	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of January 29, 2024.

Content

The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of January 29, 2024.